Mr. Chair, on the first issue about suspension, when putting in measures at either the legislative or regulatory level, you need to look at what the instrument does. Recall is introduced at the act level. Suspension is something that Health Canada can do under the current regulations. It really has to do with how the authorization works. As Health Canada approves a product out on the market, it does so with a threshold. It looks at the product and it says that the benefits outweigh the risks and the chemistry is okay.
If we see something that gives us concern, then we can reach for a suspension, and that will still be effective under this current set of proposals. You're really looking for.... If we start to see that there's a serious risk introduced and the drug shouldn't be sold anymore, then we can invoke suspension. Recall, though, is also where you need to reach into the market and pull the product back from the market or correct it.